EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health and Personalised Care

Zobair M Younossi iD, Vincent Wai-Sun Wong iD, Emmanuel A Tsochatzis, Laurent Castera, Michael Betel, Linda Henry iD, Shira Zelber Sagi iD

Liver International · 2025-10 · 45 (10)

DOI: 10.1111/liv.70311 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 17.09.2025. Verfasst von Zobair M Younossi und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Global MASH Council, Washington, DC, USA. Hauptthemen laut MEDLINE: Public Health, Precision Medicine, Health Care Reform, Fatty Liver. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: The Global NASH Council, Novo Nordisk Fonden, Siemens.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is growing in prevalence around the world, with a current global prevalence rate of 38%. Although MASLD serves as an umberlla term, its subtype of metabolic dysfunction associated steatohepatitis (MASH) with a prevalence of 5‐7%, can lead to adverse liver outcomes including cirrhosis and liver mortality. However, prevalence rates for MASLD/MASH vary by country and region of the world. With the increasing rates of type 2 diabetes and obesity, MASLD/MASH is increasing and is currently among the top causes of hepatocellular carcinoma and an indication for liver transplantation in the United States. Therefore, the care model is shifting to prevention given this large clinical, economic and humanistic burden of this liver disease. As in other noncommunicable diseases, interventional priorities for policymakers should be focused on building infrastructure that supports physical activity and healthy food choices as well as access to approved treatments for MASLD. At the same time, identifying individuals at risk for adverse outcomes using non‐invasive tests and developing individual care plans that address the needs of each patient with MASLD, including their mental and physical health, should be a focus for healthcare providers. Furthermore, raising awareness among patients, the public and healthcare providers continues to be a crucial need. This report will provide recommendations for policymakers to provide the needed interventions to reverse the current trajectory of this liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Public HealthPrecision MedicineHealth Care ReformFatty LiverHumansPrevalenceHealth PolicyGastroenterologyUnited StatesLiver Transplantation

Stichwörter der Autor:innen

MASHMASLDNITsPolicyawarenesslifestylepatient perspective

Autor:innen und Institutionen

  • The Global MASH Council, Washington, DC, USA.
  • Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.
  • Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
  • Department of Hepatology, Beaujon Hospital, AP-HP, Université Paris-Cité, Clichy, France.
  • Fatty Liver Alliance, Toronto, Ontario, Canada.

ORCID-Profile: Zobair M Younossi, Vincent Wai-Sun Wong, Linda Henry, Shira Zelber Sagi

Förderung

  • The Global NASH Council
  • Novo Nordisk Fonden
  • Siemens

Zitieren

APA

Younossi, Z. M., Wong, V. W., Tsochatzis, E. A., Castera, L., Betel, M., Henry, L., & Sagi, S. Z. (2025). Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health and Personalised Care. Liver International, 45(10). https://doi.org/10.1111/liv.70311

Vancouver

Younossi ZM, Wong VW, Tsochatzis EA, Castera L, Betel M, Henry L, et al. Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health and Personalised Care. Liver International. 2025;45(10). doi:10.1111/liv.70311

BibTeX
@article{Younossi2025,
  author = {Younossi, Zobair M and Wong, Vincent Wai-Sun and Tsochatzis, Emmanuel A and Castera, Laurent and Betel, Michael and Henry, Linda and Sagi, Shira Zelber},
  title = {Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health and Personalised Care},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {10},
  doi = {10.1111/liv.70311}
}
Kostenlos starten →